Who benefits behind the scenes from high prescription drug prices?
By
Alan G. Rosenbloom
Oct 16, 2023
If there’s one thing most Americans still agree on, it’s that the ever-increasing cost of healthcare is simply unsustainable. And while there is plenty of blame to go around, one must look at who benefits...
Drug pricing reform deal may allow Medicare to negotiate with drug firms for first time
By
Alicia Lasek
Nov 04, 2021
The Democrats’ deal also would limit insulin costs and cap annual out-of-pocket spending at $2,000 for seniors. Pharmacy benefit managers would face transparency requirements as well.
Clinical briefs for Wednesday, June 2
By
Alicia Lasek
Jun 02, 2021
Widespread inaction on hearing loss revealed in new poll of U.S. adults … Small pharmacies cheer Texas’ passage of PBM middleman reform law … Employers can require COVID vaccine under new EEOC guidance...
PBMs must stop taking advantage of seniors and taxpayers
By
Alan G. Rosenbloom
Sep 24, 2018
out-of-control prescription drug pricing is most certainly hurting American seniors and the LTC pharmacies committed to ensuring access to medications and consulting services for Medicare beneficiaries...
Trump prescription plan doesn’t include Medicare-negotiated pricing
By
Kimberly Marselas
May 14, 2018
President Donald Trump’s “blueprint” for lowering prescription costs goes after pharmacy benefit managers but stops short of recommending Medicare-negotiated prices, a plank he campaigned...
Advisory panel targets ‘outsized profits’ for pharmacy benefit managers
By
Kimberly Marselas
Feb 13, 2018
A new federal report examining ways to drive down drug pricing drew praise Monday from industry observers for criticizing a “lack of transparency” among the pharmacy benefit managers dominating...